Other authors [28,29] have reported that an increased AST/ALT ratio and lower ALT levels are associated with the diagnosis of AD, and these changes are related to increased Aβ deposition, higher levels of phosphorylated and total τ-protein in cerebrospinal fluid, as well as decreased cerebral glucose metabolism and greater brain atrophy. Here, GPT is linked to Alzheimer disease.